Peripheral neuropathy and diabetes: severity, management and future perspectives

Abstract

Diabetic neuropathy is a heterogeneous gathering of problems with very complicated pathophysiology furthermore, influences both physical and autonomic parts of the sensory system. Neuropathy is the most common persistent inconvenience of diabetes mellitus. Metabolic interruptions in the peipheral sensory system, including changed protein kinase C action, and expanded polyol pathway action in neurons and Schwann cells coming about because of hyperglycemia assumes a vital part in the advancement of diabetic neuropathy. These pathways are connected with the metabolic and additionally redox condition of the cell and are the significant source of harm. When this metabolic pathways activates it leads to oxidative stress which also activate hyperglycemia induced injury of cells and result into diabetic neuropathy. Though the problem is very common and serious therapeutics which target one particular mechanism has a very limited success rate. The approaches which are available basically depends on agents which modulate pathogenetic mechanisms (glycemic control) and minimize diabetic neuropathy symptoms. This review discuss the pathogenesis, as of now accessible remedial methodologies and future bearings for the administration of diabetic neuropathy.